Seminar on Insurance Coverage Strategies for Medical Devices in Light of the 2026 Medical Fee Revision Held – Jiji.com

News Highlights

A seminar on insurance coverage strategies for medical devices was held, looking ahead to the 2026 fiscal year’s medical fee revision. The news highlights point to mid-to-long-term management and succession strategies based on the revision cycle, economies of scale through group participation, and utilization of tax schemes including conversion to specific medical corporations and social medical corporations as key discussion points.

Perspective from the M&A Medical Editorial Department

The holding of a seminar directly linking the 2026 fiscal year medical fee revision to insurance coverage strategies for medical devices is a development that medical institution managers cannot ignore. In particular, the implication of mid-to-long-term management and succession strategies that consider the revision cycle is significant. It is essential to formulate business plans that incorporate external factors like medical fee revisions, rather than merely focusing on capital investment. Furthermore, the “economies of scale” from group participation can lead to cost dispersion for introducing the latest equipment, which is a significant burden for individual medical institutions, and for maintaining facility standards. This could serve as an incentive for business expansion or strengthening collaboration through M&A. Tax schemes, such as conversion to specific medical corporations or social medical corporations, can also be considered as options for business succession and organizational restructuring from the initial stages of M&A consideration.

Discussion Points Indicated by This News

• Suggests that the 2026 fiscal year medical fee revision will directly impact insurance coverage strategies for medical devices.
• The necessity of incorporating trends in medical fee revisions into mid-to-long-term management and succession strategies is increasing.
• Economies of scale through group formation are effective for maintaining facility standards and dispersing the burden of capital investment.
• Tax schemes, including conversion to specific medical corporations and social medical corporations, may be key to management and succession strategies.

Practical Questions Arising from This News

• What specific insurance coverage strategies for medical devices were discussed in this seminar?
• What specific cost reductions or revenue increases can be achieved through economies of scale from group formation?
• What are the merits and demerits of converting to specific medical corporations and social medical corporations, and what is an overview of the procedures?

If You Feel “Should I Consult Too?”

Medical institution managers who are anxious about responding to the 2026 fiscal year medical fee revision, wish to disperse the cost burden of introducing the latest medical equipment, or are considering an organizational structure with future business succession in mind should consider consulting with experts prompted by this news. Group formation through M&A or organizational restructuring utilizing tax schemes may offer a path to resolving these issues.

M&A Medical (CentralMedience Inc.) supports business succession for medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultation here